loanDepot (LDI) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates


For the quarter ended December 2023, Cinemark Holdings (CNK) reported revenue of $638.9 million, up 6.5% over the same period last year. EPS came in at -$0.15, compared to -$0.82 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $619.8 million, representing a surprise of +3.08%. The company delivered an EPS surprise of +6.25%, with the consensus EPS estimate being -$0.16.

While investors closely watch year-over-year changes in headline numbers — revenue and earnings — and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company’s underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock’s price performance.

Here is how Cinemark performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Average ticket price – U.S. Operating Segment: $10.21 versus $10.23 estimated by two analysts on average.
  • Average ticket price – International Operating Segment: $3.81 compared to the $3.84 average estimate based on two analysts.
  • Concession revenues per patron – U.S. Operating Segment: $7.67 compared to the $7.71 average estimate based on two analysts.
  • Attendance – International Operating Segment: 14.4 million versus the two-analyst average estimate of 14.13 million.
  • Revenue- International Operating Segment- Admissions: $54.90 million versus the two-analyst average estimate of $54.21 million. The reported number represents a year-over-year change of +2.6%.
  • Revenue- U.S. Operating Segment- Admissions: $267.50 million versus $259.59 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +6.5% change.
  • Revenue- U.S. Operating Segment- Other: $50.40 million compared to the $48.13 million average estimate based on two analysts. The reported number represents a change of +4.8% year over year.
  • Revenue- U.S. Operating Segment- Concession: $200.90 million versus the two-analyst average estimate of $195.67 million. The reported number represents a year-over-year change of +7.7%.
  • Revenue- International Operating Segment- Other: $23.10 million versus the two-analyst average estimate of $21.84 million. The reported number represents a year-over-year change of +8.5%.
  • Revenue- Admissions: $322.40 million versus $313.65 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +5.8% change.
  • Revenue- Other: $73.50 million versus $70.09 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +5.9% change.
  • Revenue- Concession: $243 million compared to the $236.06 million average estimate based on six analysts. The reported number represents a change of +7.7% year over year.

View all Key Company Metrics for Cinemark here>>>

Shares of Cinemark have returned +20.5% over the past month versus the Zacks S&P 500 composite’s +5.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.0% per year. So be sure to give these hand-picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Cinemark Holdings Inc (CNK) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



Image and article originally from www.nasdaq.com. Read the original article here.

By Zacks